Breast Cancer

PET imaging still questionable as means of predicting chemotherapy response

Published in Cancer Weekly, December 2nd, 2003

While early detection and new drug therapies have contributed significantly to the battle against breast cancer, doctors continue to search for better methods to improve patients' odds of survival.

Higher-risk forms of cancer, such as locally advanced breast cancer (LABC), are often treated with chemotherapy prior to surgery in order to enhance the probability of surgical success. Predicting the effectiveness of this pre-surgery chemotherapy can spare patients exposure to ineffective treatment and save money in the long run.

Recently, a team of University of Washington researchers conducted a study to determine if 18F-FDG and 15O-water PET (positron...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2003-12-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry